The Hepatic Microenvironment Uniquely Protects Leukemia Cells through Induction of Growth and Survival Pathways Mediated by LIPG

Due to the disseminated nature of leukemia, malignant cells are exposed to many different tissue microenvironments, including a variety of extramedullary sites. In the present study, we demonstrate that leukemic cells residing in the liver display unique biological properties and also contribute to...

Full description

Saved in:
Bibliographic Details
Published in:Cancer discovery 2021-02, Vol.11 (2), p.500-519
Main Authors: Ye, Haobin, Minhajuddin, Mohammad, Krug, Anna, Pei, Shanshan, Chou, Chih-Hsing, Culp-Hill, Rachel, Ponder, Jessica, De Bloois, Erik, Schniedewind, Björn, Amaya, Maria L, Inguva, Anagha, Stevens, Brett M, Pollyea, Daniel A, Christians, Uwe, Grimes, H Leighton, D'Alessandro, Angelo, Jordan, Craig T
Format: Article
Language:English
Subjects:
Animals
Cell Proliferation
Disease Models, Animal
Humans
Leukemia - metabolism
Lipase - metabolism
Liver - metabolism
Liver - pathology
Mice
Mice, Inbred C57BL
Tumor Microenvironment
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Due to the disseminated nature of leukemia, malignant cells are exposed to many different tissue microenvironments, including a variety of extramedullary sites. In the present study, we demonstrate that leukemic cells residing in the liver display unique biological properties and also contribute to systemic changes that influence physiologic responses to chemotherapy. Specifically, the liver microenvironment induces metabolic adaptations via upregulating expression of endothelial lipase in leukemia cells, which not only stimulates tumor cell proliferation through polyunsaturated fatty acid-mediated pathways, but also promotes survival by stabilizing antiapoptotic proteins. Additionally, hepatic infiltration and tissue damage caused by malignant cells induces release of liver-derived enzymes capable of degrading chemotherapy drugs, an event that further protects leukemia cells from conventional therapies. Together, these studies demonstrate a unique role for liver in modulating the pathogenesis of leukemic disease and suggest that the hepatic microenvironment may protect leukemia cells from chemotherapeutic challenge. SIGNIFICANCE: The studies presented herein demonstrate that the liver provides a microenvironment in which leukemia cells acquire unique metabolic properties. The adaptations that occur in the liver confer increased resistance to chemotherapy. Therefore, we propose that therapies designed to overcome liver-specific metabolic changes will yield improved outcomes for patients with leukemia. .
ISSN:2159-8274
2159-8290
DOI:10.1158/2159-8290.CD-20-0318